State Street’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

State Street’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,127	Closed	-$12.1K	–	4592
2023 Q3	$12.1K	Hold	30,127	–	–	﹤0.01%	4494
2023 Q2	$20.8K	Hold	30,127	–	–	﹤0.01%	4587
2023 Q1	$238K	Buy	30,127 +8,800	+41%	+$30.6K	﹤0.01%	4016
2022 Q4	$19.2K	Hold	21,327	–	–	﹤0.01%	4736
2022 Q3	$23K	Hold	21,327	–	–	﹤0.01%	4814
2022 Q2	$26K	Hold	21,327	–	–	﹤0.01%	4848
2022 Q1	$50K	Hold	21,327	–	–	﹤0.01%	4795
2021 Q4	$66K	Hold	21,327	–	–	﹤0.01%	4656
2021 Q3	$87K	Buy	21,327 +300	+1%	+$1.25K	﹤0.01%	4576
2021 Q2	$102K	Sell	21,027 -35,969	-63%	-$161K	﹤0.01%	4363
2021 Q1	$296K	Sell	56,996 -22,581	-28%	-$157K	﹤0.01%	3794
2020 Q4	$531K	Buy	79,577 +20,500	+35%	+$168K	﹤0.01%	3638
2020 Q3	$601K	Buy	59,077 +26,775	+83%	+$315K	﹤0.01%	3543
2020 Q2	$405K	Buy	+32,302	New	+$452K	﹤0.01%	3565
2020 Q1	–	Sell	-920	Closed	-$5K	–	3825
2019 Q4	$5K	Hold	920	–	–	﹤0.01%	3802
2019 Q3	$7K	Hold	920	–	–	﹤0.01%	3798
2019 Q2	$8K	Hold	920	–	–	﹤0.01%	3802
2019 Q1	$9K	Hold	920	–	–	﹤0.01%	3730
2018 Q4	$11K	Hold	920	–	–	﹤0.01%	3732
2018 Q3	$15K	Hold	920	–	–	﹤0.01%	3749
2018 Q2	$33K	Hold	920	–	–	﹤0.01%	3704
2018 Q1	$29K	Buy	+920	New	+$29.3K	﹤0.01%	3696

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

State Street's BLPH Position: Q4 2023 in Review

State Street sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 30,127 shares — an estimated $12.1K sold.

State Street first reported a position in BLPH in Q1 2018 and held it in 22 quarters. The position peaked at $601K in Q3 2020. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

State Street reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
State Street sold 30,127 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $12.1K.
State Street first reported a position in Bellerophon Therapeutics, Inc. in Q1 2018 and held it in 22 quarters.
State Street's Bellerophon Therapeutics, Inc. position peaked at $601K in Q3 2020.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.